137 related articles for article (PubMed ID: 2459613)
21. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
Kawanami S; Tsuji R; Oda K
Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
[TBL] [Abstract][Full Text] [Related]
22. Influence of immunological fine-specificity on the induction of experimental myasthenia gravis.
Krolick KA; Thompson PA; Zoda TE; Yeh TM
Ann N Y Acad Sci; 1993 Jun; 681():179-97. PubMed ID: 7689305
[No Abstract] [Full Text] [Related]
23. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
Yi Q; Lefvert AK
J Immunol; 1994 Oct; 153(7):3353-9. PubMed ID: 8089503
[TBL] [Abstract][Full Text] [Related]
24. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
Nagvekar N; Moody AM; Moss P; Roxanis I; Curnow J; Beeson D; Pantic N; Newsom-Davis J; Vincent A; Willcox N
J Clin Invest; 1998 May; 101(10):2268-77. PubMed ID: 9593783
[TBL] [Abstract][Full Text] [Related]
25. Sharing of epitopes by bacteria and the nicotinic acetylcholine receptor: a possible role in the pathogenesis of myasthenia gravis.
Stefansson K; Dieperink ME; Richman DP; Marton LS
Ann N Y Acad Sci; 1987; 505():451-60. PubMed ID: 2446557
[No Abstract] [Full Text] [Related]
26. CD4+ T-epitope repertoire on the human acetylcholine receptor alpha subunit in severe myasthenia gravis: a study with synthetic peptides.
Manfredi AA; Protti MP; Wu XD; Howard JF; Conti-Tronconi BM
Neurology; 1992 May; 42(5):1092-100. PubMed ID: 1374548
[TBL] [Abstract][Full Text] [Related]
27. An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptide.
Nicolle MW; Vincent A; Sharma S; Nag B; Willcox N; Newsom-Davis J
Ann N Y Acad Sci; 1993 Jun; 681():577-80. PubMed ID: 8357203
[No Abstract] [Full Text] [Related]
28. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
Barkas T; Simpson JA
J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
[TBL] [Abstract][Full Text] [Related]
29. T-cell-helper factors in autoimmunity.
Mozes E; Mendlovic S; Bentwich Z; Brautbar C; Shoenfeld Y
Isr J Med Sci; 1988 Jul; 24(7):355-8. PubMed ID: 2457001
[No Abstract] [Full Text] [Related]
30. Amphipathic segment of the nicotinic receptor alpha subunit contains epitopes recognized by T lymphocytes in myasthenia gravis.
Hohlfeld R; Toyka KV; Miner LL; Walgrave SL; Conti-Tronconi BM
J Clin Invest; 1988 Mar; 81(3):657-60. PubMed ID: 2449458
[TBL] [Abstract][Full Text] [Related]
31. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.
Fujii Y; Lindstrom J
J Immunol; 1988 Nov; 141(10):3361-9. PubMed ID: 2972772
[TBL] [Abstract][Full Text] [Related]
32. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
Brocke S; Brautbar C; Steinman L; Abramsky O; Rothbard J; Neumann D; Fuchs S; Mozes E
J Clin Invest; 1988 Dec; 82(6):1894-900. PubMed ID: 2461962
[TBL] [Abstract][Full Text] [Related]
33. Homology between Fas and nicotinic acetylcholine receptor protein in a thymoma with myasthenia gravis--immunohistochemical and biochemical study.
Kawanami S; Mori S; Ueda H
Fukuoka Igaku Zasshi; 2000 May; 91(5):123-31. PubMed ID: 10916854
[TBL] [Abstract][Full Text] [Related]
34. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide.
Atassi MZ; Ruan KH; Jinnai K; Oshima M; Ashizawa T
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5852-6. PubMed ID: 1378618
[TBL] [Abstract][Full Text] [Related]
35. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes.
Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM
J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune diseases involving nicotinic receptors.
Lindstrom J
J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
[TBL] [Abstract][Full Text] [Related]
37. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
Tzartos SJ
In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
[TBL] [Abstract][Full Text] [Related]
38. Specific immunoadsorption of the autoantibodies from myasthenic patients using the extracellular domain of the human muscle acetylcholine receptor alpha-subunit. Development of an antigen-specific therapeutic strategy.
Psaridi-Linardaki L; Trakas N; Mamalaki A; Tzartos SJ
J Neuroimmunol; 2005 Feb; 159(1-2):183-91. PubMed ID: 15652418
[TBL] [Abstract][Full Text] [Related]
39. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.
Christadoss P; Shenoy M; Oshima M; Atassi MZ
Adv Exp Med Biol; 1994; 347():65-75. PubMed ID: 7976734
[No Abstract] [Full Text] [Related]
40. Myasthenia gravis patients, but not healthy subjects, recognize epitopes that are unique to the epsilon-subunit of the acetylcholine receptor.
Ragheb S; Mohamed M; Lisak RP
J Neuroimmunol; 2005 Feb; 159(1-2):137-45. PubMed ID: 15652413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
